D
Deborah J. Cook
Researcher at McMaster University
Publications - 942
Citations - 165225
Deborah J. Cook is an academic researcher from McMaster University. The author has contributed to research in topics: Intensive care & Randomized controlled trial. The author has an hindex of 173, co-authored 907 publications receiving 148928 citations. Previous affiliations of Deborah J. Cook include McMaster University Medical Centre & Queen's University.
Papers
More filters
Journal ArticleDOI
Research ethics board approval for an international thromboprophylaxis trial
Kristina Lutz,Kelly Wilton,Nicole Zytaruk,Lisa Julien,Richard I. Hall,Johanne Harvey,Yoanna Skrobik,Nicholas E. Vlahakis,Laurie Meade,Andrea Matte,Maureen O. Meade,Karen E. A. Burns,Martin Albert,Bronwyn Barlow Cash,Shirley Vallance,James R. Klinger,Diane Heels-Ansdell,Deborah J. Cook +17 more
TL;DR: The objectives of this study were to examine the time from submission to approval, to analyze predictors of approval time, and to describe the scope of conditions from REBs evaluating an international thromboprophylaxis trial.
Journal Article
Review: Albumin does not reduce death in critically ill patients with hypovolemia, burns, or hypoalbuminemia
TL;DR: Human albumin adnumstration in critically ill patients in Cochrane Review, latest version 22 May 1998.
Journal ArticleDOI
Family and Clinician Experiences of Sympathy Cards in the 3 Wishes Project.
Alyson Takaoka,Meredith Vanstone,Thanh H. Neville,Sophia Goksoyr,Marilyn Swinton,Orla Smith,Allana LeBlanc,Denise Foster,Yuhan Kao,Xueqing Xu,Neala Hoad,Feli Toledo,Deborah J. Cook +12 more
TL;DR: Inviting clinicians who cared for deceased patients to offer personalized, handwritten condolences to bereaved family members may cultivate sincere and individualized expressions of sympathy that bereaved families appreciate after the death of patients involved in the 3 Wishes Project.
Journal ArticleDOI
Applying the findings of clinical trials to individual patients.
Journal ArticleDOI
Does Fibronectin Reduce Mortality in Sepsis? A Meta-Analysis
TL;DR: The results do not show a statistically significant effect favoring treatment, but neither do they exclude a clinically important benefit, and the benefit of fibronectin in decreasing mortality in sepsis is not sup ported by these studies.